Cargando...
Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer
Intravesical bacillus Calmette–Guérin (BCG) immunotherapy has been the gold standard adjuvant treatment for intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) after transurethral resection of bladder tumor (TURBT). BCG immunotherapy prevents disease recurrence and progression to...
Guardado en:
| Publicado en: | Investig Clin Urol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
The Korean Urological Association
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246016/ https://ncbi.nlm.nih.gov/pubmed/34085791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.20200602 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|